• Publications
  • Influence
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
BACKGROUND If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel node, axillary lymph node dissection is the present standard. Although axillary lymphExpand
  • 768
  • 47
  • PDF
Lymphedema following axillary lymph node dissection for breast cancer.
Lymphedema is a relatively common, potentially serious and unpleased complication after axillary lymph node dissection (ALND) for breast cancer. It may be associated with functional, esthetic, andExpand
  • 192
  • 16
Quality indicators in breast cancer care.
To define a set of quality indicators that should be routinely measured and evaluated to confirm that the clinical outcome reaches the requested standards, Eusoma has organised a workshop duringExpand
  • 164
  • 9
  • PDF
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer
The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women withExpand
  • 280
  • 7
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of
The aim of this study is the counting and the immunomorphological and molecular characterization of circulating tumor cells (CTCs) by the isolation by size of epithelial tumor cells (ISET) method inExpand
  • 171
  • 7
  • PDF
The requirements of a specialist Breast Centre.
INTRODUCTION In recognition of the advances and evidence based changes in clinical practice that have occurred in recent years and taking into account the knowledge and experience accumulated throughExpand
  • 126
  • 6
  • PDF
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy.
BACKGROUND The need to dissect axillary nodes in patients with early breast cancer and clinically negative axilla remains controversial. The aim of the study was to assess the role of axillaryExpand
  • 151
  • 6
European guidelines for quality assurance in the surgical management of mammographically detected lesions.
European guidelines for quality assurance in the surgical management of mammographically detected lesions.
  • 67
  • 6
Quality indicators in breast cancer care: An update from the EUSOMA working group.
In 2010, EUSOMA published a position paper, describing a set of benchmark quality indicators (QIs) that could be adopted by breast centres to allow standardised auditing and quality assurance and toExpand
  • 62
  • 5
  • PDF
Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial.
PURPOSE To evaluate with a randomized clinical trial the possibility of treating the index quadrant with external intensity-modulated radiotherapy (IMRT) in a selected group of patients withExpand
  • 92
  • 4